On last quarters sales, we get an annual revenue run rate of $1.25Billion for Illucix alone, and still taking market share. Enter Gozellix, a myriad of products in the pipeline, and global jurisdictional expansion and sky is the limit. Share price would be easy over $40 if not for Trump reference pricing proposals and associated uncertainty. My opinions only.
Ann: Telix Reports US$204M Q2 Revenue, Up 63% YOY, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$20.52 |
Change
-0.570(2.70%) |
Mkt cap ! $6.959B | |||
| Open | High | Low | Value | Volume |
| $21.05 | $21.08 | $20.50 | $29.78M | 1.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2279 | $21.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.47 | 6757 | 2 |
View Market Depth
| Last trade - 15.59pm 29/07/2025 (20 minute delay) ? |
| TLX (ASX) Chart |